PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 5, 2024Journal of Psychedelic Studies4 citations

Seeing the forest for the trees: An ecological systems theory approach to addressing emergent issues in psychedelic-assisted therapy research

View Full Paper
MDMeghan DellaCrosseAGAlbert Garcia‐RomeuADAlan K. Davis

Key Points

Key points are not available for this paper at this time.

Abstract

Abstract Despite growing interest in psychedelic-assisted therapy (PAT) research, there remains a lack of consensus about key issues relevant to difficulties in predicting acute drug effects, and the role of therapeutic support in clinical trials. In the absence of a clear theoretical model to conceptualize multifaceted components in PAT research, dialogue across contexts (e.g., popular media, peer reviewed journals, conference settings) is becoming increasingly polarized and siloed. This has even contributed to somewhat unusual recommendations by the FDA and others that removing critical aspects of psychological and medical safety could enhance our ability to investigate the impact of these drugs on clinical outcomes. Considering the importance of determining and maximizing safety in ongoing PAT research, this commentary suggests that an ecological systems theory (EST) approach provides a structure to make contextual and practical factors a more explicit and testable component of research. Utilizing systems theory and Bronfenbrenner’s EST approach adapted for healthcare settings, we propose that a more detailed conceptual model in PAT research would enable more explicit consideration of contextual factors informing and influencing outcomes. This commentary is accompanied by a custom figure that illustrates application of this model for psychedelic research and highlights the limitations of current measurement of acute subjective experience.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

DellaCrosse et al. (2024) studied this question.

synapsesocial.com/papers/68e660cfb6db6435875eeb42https://doi.org/10.1556/2054.2024.00374
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Commentary on methods for addressing functional unblinding and mechanistic uncertainty in clinical trials of psychedelic-assisted treatments2025
  2. 2Psychedelic-assisted therapy as a complex intervention: implications for clinical trial design2025 · 12 citations
  3. 3Commentary on Methods for Addressing Functional Unblinding and Mechanistic Uncertainty in Clinical Trials of Psychedelic-Assisted Treatments2025
  4. 4A framework for assessment of adverse events occurring in psychedelic-assisted therapies2024 · 34 citations
  5. 5From Trials to Clinics: Considerations for Implementing Psychedelic‐Assisted Therapy Into Clinical Practice2026 · 1 citations